Aveanna Healthcare (NASDAQ:AVAH – Get Rating) had its target price decreased by Stephens to $2.50 in a research report report published on Tuesday, Stock Target Advisor reports.

AVAH has been the subject of several other reports. Jefferies Financial Group lowered shares of Aveanna Healthcare from a buy rating to a hold rating and set a $2.50 price objective for the company. in a research note on Friday, July 22nd. Bank of America lowered shares of Aveanna Healthcare from a neutral rating to an underperform rating and dropped their price objective for the stock from $3.00 to $2.00 in a research note on Tuesday, June 21st. Credit Suisse Group dropped their price objective on shares of Aveanna Healthcare to $5.50 in a research note on Friday, July 22nd. Barclays dropped their price objective on shares of Aveanna Healthcare from $7.00 to $5.00 and set an overweight rating for the company in a research note on Friday, August 19th. Finally, Truist Financial lowered shares of Aveanna Healthcare from a buy rating to a hold rating and set a $2.50 price objective for the company. in a research note on Tuesday, July 5th. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating, five have assigned a buy rating and one has given a strong buy rating to the company's stock. Based on data from MarketBeat, Aveanna Healthcare has a consensus rating of Moderate Buy and a consensus price target of $5.30.

Aveanna Healthcare Trading Up 1.2 %

AVAH stock opened at $1.69 on Tuesday. The firm has a fifty day moving average price of $2.23 and a 200 day moving average price of $3.19. Aveanna Healthcare has a fifty-two week low of $1.66 and a fifty-two week high of $9.73. The company has a debt-to-equity ratio of 6.19, a quick ratio of 0.81 and a current ratio of 0.81. The firm has a market cap of $314.20 million, a PE ratio of -0.56 and a beta of 1.03.

Institutional Trading of Aveanna Healthcare

Institutional investors and hedge funds have recently made changes to their positions in the company. Regentatlantic Capital LLC purchased a new stake in shares of Aveanna Healthcare during the first quarter worth about $34,000. Zurcher Kantonalbank Zurich Cantonalbank purchased a new stake in shares of Aveanna Healthcare during the second quarter worth about $25,000. AE Wealth Management LLC purchased a new stake in shares of Aveanna Healthcare during the second quarter worth about $31,000. Virginia Retirement Systems ET AL purchased a new stake in shares of Aveanna Healthcare during the first quarter worth about $50,000. Finally, SG Americas Securities LLC purchased a new stake in shares of Aveanna Healthcare during the second quarter worth about $38,000. 92.00% of the stock is currently owned by institutional investors.

About Aveanna Healthcare

(Get Rating)

Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides private duty nursing (PDN), adult home health and hospice, home-based pediatric therapy, and enteral nutrition services in the United States. Its patient- centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals.

See Also

• Get a free copy of the StockNews.com research report on Aveanna Healthcare (AVAH)
• 3 Low Beta Defensive Stocks for a Tough Market
• It Could Be a September to Remember for These 3 Stocks
• Peak Inflation Sets the Bottom for Brinker International Stock
• Can Roblox Reverse its Falling Bookings Amid Rising Engagements
• Broadcom Bounces From Institutional Bottom

Receive News & Ratings for Aveanna Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aveanna Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.